Allergan PLC (AGN)

• Annual Data
• Quarterly Data

Allergan PLC, Common-Size Consolidated Income Statement

Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18), 10-K (filing date: 2014-02-25).

Item	Description	The company
Operating loss	The net result for the period of deducting operating expenses from operating revenues.	Allergan PLC’s operating loss as a percentage of net revenues increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Loss before income taxes and noncontrolling interest	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Allergan PLC’s loss before income taxes and noncontrolling interest as a percentage of net revenues increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Net income (loss) attributable to shareholders	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Allergan PLC’s net income (loss) attributable to shareholders as a percentage of net revenues increased from 2015 to 2016 but then declined significantly from 2016 to 2017.